methylprednisolone and tamoxifen

methylprednisolone has been researched along with tamoxifen in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19902 (13.33)18.7374
1990's1 (6.67)18.2507
2000's4 (26.67)29.6817
2010's7 (46.67)24.3611
2020's1 (6.67)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Asselain, B; Coutant, M; Dorval, T; Garcia-Giralt, E; Jouve, M; Magdelenat, H; Palangie, T; Pouillart, P1
Pons, JY1
Allendorff, J; Köhler, H; Riegel, W1
Geniaux, M; Labbe, L; Sibaud, V; Toussaint, P1
Dabelic, N; Jukic, T; Kusic, Z; Labar, Z; Matesa, N; Novosel, SA1
Georgopoulou, V; Harsoulis, F; Karagiannis, A; Krikis, N; Perifanis, V; Rizopoulou, D; Tziomalos, K1
Hsia, CC; Hsu, YH; Huang, JW; Hung, KY; Tsai, DM; Tu, HY1
Ago, T; Hotta, T; Kang, D; Kitazono, T; Matsumoto, S; Nakamura, K; Ueki, K; Wada, S; Wakisaka, Y; Yoshikawa, Y1

Reviews

1 review(s) available for methylprednisolone and tamoxifen

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for methylprednisolone and tamoxifen

ArticleYear
[Metastatic breast cancer. Modality of association of chemotherapy and hormonotherapy. Results of a controlled trial].
    Bulletin du cancer, 1987, Volume: 74, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Synergism; Female; Fluorouracil; Humans; Methylprednisolone; Middle Aged; Neoplasm Metastasis; Random Allocation; Tamoxifen

1987

Other Studies

13 other study(ies) available for methylprednisolone and tamoxifen

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010
QSAR-based permeability model for drug-like compounds.
    Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8

    Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2011
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
[Mastodynia and fibrocystic disease of the breast].
    Journal de gynecologie, obstetrique et biologie de la reproduction, 1987, Volume: 16, Issue:1

    Topics: Female; Fibrocystic Breast Disease; Humans; Methylprednisolone; Premenstrual Syndrome; Tamoxifen

1987
[Regression of retroperitoneal fibrosis by combination therapy with tamoxifen and steroids].
    Medizinische Klinik (Munich, Germany : 1983), 1997, Jul-15, Volume: 92, Issue:7

    Topics: Aged; Anti-Inflammatory Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Estrogen Antagonists; Female; Follow-Up Studies; Humans; Methylprednisolone; Middle Aged; Retroperitoneal Fibrosis; Tamoxifen; Tomography, X-Ray Computed; Treatment Outcome

1997
[POEMS syndrome revealed by a scleroderma-like skin thickening].
    Annales de dermatologie et de venereologie, 2000, Volume: 127, Issue:1

    Topics: Anti-Inflammatory Agents; Biopsy; Diagnosis, Differential; Female; Humans; Methylprednisolone; Middle Aged; Plasmapheresis; POEMS Syndrome; Scleroderma, Systemic; Selective Estrogen Receptor Modulators; Skin; Tamoxifen

2000
Riedel's thyroiditis treated with tamoxifen.
    Croatian medical journal, 2003, Volume: 44, Issue:2

    Topics: Croatia; Drug Therapy, Combination; Female; Goiter; Humans; Methylprednisolone; Middle Aged; Tamoxifen; Thyroiditis; Thyroxine; Tomography, X-Ray Computed

2003
Treatment of idiopathic retroperitoneal fibrosis with combined administration of corticosteroids and tamoxifen.
    Clinical nephrology, 2004, Volume: 62, Issue:1

    Topics: Adult; Diagnosis, Differential; Drug Therapy, Combination; Humans; Male; Methylprednisolone; Retroperitoneal Fibrosis; Tamoxifen; Tomography, X-Ray Computed

2004
Development of encapsulating peritoneal sclerosis following bacterial peritonitis in a peritoneal dialysis patient.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2010, Volume: 55, Issue:1

    Topics: Adult; Antineoplastic Agents, Hormonal; Bacterial Infections; Diagnosis, Differential; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Kidney Failure, Chronic; Methylprednisolone; Peritoneal Dialysis; Peritoneal Fibrosis; Peritonitis; Tamoxifen; Tomography, X-Ray Computed

2010
An Embolic Stroke in a Patient With PROC p.Lys193del.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2020, Volume: 29, Issue:5

    Topics: Anticoagulants; Antineoplastic Agents, Hormonal; Blood Coagulation; Female; Genetic Predisposition to Disease; Glucocorticoids; Humans; Intracranial Embolism; Methylprednisolone; Middle Aged; Neuroprotective Agents; Phenotype; Protein C; Protein C Deficiency; Recurrence; Risk Factors; Sequence Deletion; Stroke; Tamoxifen; Treatment Outcome

2020